Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

Merrimack Pharmaceuticals CEO and leadership

Zippia score 4.6
OverviewSalaryRevenue

Reviews

HistoryDemographicsCompetitors

CEO & Executives

Merrimack Pharmaceuticals CEO and executives

Executive Summary. Based on our data team's research, Gary L. Crocker is the Merrimack Pharmaceuticals's CEO. Merrimack Pharmaceuticals has 426 employees, of which 22 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Merrimack Pharmaceuticals executive team is 18% female and 82% male.
  • 69% of the management team is White.
  • 11% of Merrimack Pharmaceuticals management is Hispanic or Latino.
  • 11% of the management team is Black or African American.
Work at Merrimack Pharmaceuticals?
Share your experience

Rate Merrimack Pharmaceuticals' leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Gary L. Crocker

Chairman, President, CEO, CFO & Treasurer

Ulrik B. Nielsen

Board Member

Gavin MacBeath

Founder

Richard Peters

Board Member

Richard Peters's LinkedIn

Dr. Peters is currently the Senior Vice President and Head of Rare Diseases at Sanofi Genzyme and prior to that, he was the Division Medical Officer of Sanofi’s Hematology and Oncology Division. Dr. Peters has over 20 years of biotech experience including roles of increasing responsibility in medical affairs at Amgen, Onyx and Genzyme. Earlier in his career, Dr. Peters was CEO of Mednav. Dr. Peters graduated with his MD and PhD from Medical University of South Carolina.

Russ T. Ray

Board Member

Sergio L. Santillana

Chief Medical Officer

Sergio Santillana is a Chief Medical Officer at MERRIMACK PHARMACEUTICALS INC. He has worked as VP:Clinical R&D at ARIAD PHARMACEUTICALS INC. Sergio attended Universidad Nacional Federico Villareal ( Facultad de Psicología ) and University of Oxford.

Eric David Andersen

Board Member

Mr. Robert J. Mulroy

President and Chief Executive Officer

Mr. Robert J. Mulroy is a President and Chief Executive Officer at MERRIMACK PHARMACEUTICALS INC and is based in United States.

Noah Gabriel Levy

Board Member

Timothy R. Surgenor

Secretary

Do you work at Merrimack Pharmaceuticals?

Does the leadership team provide a clear direction for Merrimack Pharmaceuticals?

Merrimack Pharmaceuticals jobs

Merrimack Pharmaceuticals founders

Name & TitleBio
Ulrik B. Nielsen

Board Member

Gavin MacBeath

Founder

Merrimack Pharmaceuticals board members

Name & TitleBio
Gary L. Crocker

Chairman, President, CEO, CFO & Treasurer

Ulrik B. Nielsen

Board Member

Richard Peters

Board Member

Richard Peters's LinkedIn

Dr. Peters is currently the Senior Vice President and Head of Rare Diseases at Sanofi Genzyme and prior to that, he was the Division Medical Officer of Sanofi’s Hematology and Oncology Division. Dr. Peters has over 20 years of biotech experience including roles of increasing responsibility in medical affairs at Amgen, Onyx and Genzyme. Earlier in his career, Dr. Peters was CEO of Mednav. Dr. Peters graduated with his MD and PhD from Medical University of South Carolina.

Russ T. Ray

Board Member

Eric David Andersen

Board Member

Noah Gabriel Levy

Board Member

Anthony Sinskey

Board Member

Gordon Fehr

Board Member

James Dresser

Board Member

James Quigley

Board Member

Merrimack Pharmaceuticals leadership demographics

Merrimack Pharmaceuticals gender distribution in management team

  • The Merrimack Pharmaceuticals executive team is 18% female and 82% male.
  • Merrimack Pharmaceuticals is 44% female and 56% male company-wide.
Male
Male
82%
Company-wide: 56%
Female
Female
18%
Company-wide: 44%

Merrimack Pharmaceuticals executives by race

Management Team:
  • The most common ethnicity among Merrimack Pharmaceuticals executive officers is White.
  • 69% of the management team is White.
  • 11% of Merrimack Pharmaceuticals's management is Hispanic or Latino.
  • 11% of the management team is Black or African American.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 67% of employees are White.
  • 12% of employees are Asian.
  • 10% of employees are Hispanic or Latino.
  • Management team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

Merrimack Pharmaceuticals jobs nearby

Merrimack Pharmaceuticals executives FAQs

Related company executives

Working at related companies

Related company jobs

Merrimack Pharmaceuticals highest paying jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of Merrimack Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Merrimack Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Merrimack Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Merrimack Pharmaceuticals. The data presented on this page does not represent the view of Merrimack Pharmaceuticals and its employees or that of Zippia.

Merrimack Pharmaceuticals may also be known as or be related to Merrimack Pharmaceuticals Inc, MERRIMACK PHARMACEUTICALS INC and Merrimack Pharmaceuticals, Inc.